Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also received a Bachelor of Arts in journalism and was editor-in-chief of her college newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have 3 young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

Pediatric Rheumatology

Data Lacking on Biologic and JAK Inhibitor Therapies for Pediatric Rheumatology Patients

Estie Mermelstein, MSN, FNP-BC

July 16, 2021

Randomized, controlled trials in pediatric inflammatory rheumatic diseases (PiRDs) of patients who underwent bDMARDs and JAK inhibitors are reviewed.

General Rheumatology

Low Immune Response to Clostridioides difficile Treatment in Immunosuppressed Patients

Estie Mermelstein, MSN, FNP-BC

July 13, 2021

Investigators assessed the immune response to Clostridioides difficile in immunocompromised patients.

Systemic Lupus Erythematosus

Cytomegalovirus Risk Higher With Immunosuppressive Treatment for Systemic Lupus Erythematosus

Estie Mermelstein, MSN, FNP-BC

June 29, 2021

Investigators assessed the role of cell-mediated immunity in the development of cytomegalovirus infection in patients with systemic lupus erythematosus undergoing treatment with immunosuppressants.

General Rheumatology

Moderna, Pfizer-BioNTech COVID-19 Vaccines Provide Immunity in Pregnant Women

Estie Mermelstein, MSN, FNP-BC

June 28, 2021

Investigators assessed response to vaccination with the Moderna or Pfizer-BioNTech COVID-19 vaccines in pregnant and nonpregnant lactating women.

General Rheumatology

COVID-19 Antibodies Detected in Breast Milk of Vaccinated Mothers

Estie Mermelstein, MSN, FNP-BC

May 14, 2021

Investigators vaccinated exclusively or partially breastfeeding women and examined their breast milk samples to determine levels of antibodies against SARS-CoV-2.

Rheumatoid Arthritis Advisor

Tofacitinib Preserves BMD and Improves Bone Turnover for RA Patients

Estie Mermelstein, MSN, FNP-BC

May 14, 2021

The effects of 1-year of tofacitinib therapy on bone metabolism in patients with rheumatoid arthritis were examined.

Spondyloarthritis

Improvement in Nail and Axial Symptoms With Secukinumab in Patients With Psoriatic Arthritis

Estie Mermelstein, MSN, FNP-BC

May 6, 2021

The investigators reported efficacy results from the MAXIMISE trial, the first randomized controlled trial evaluating the efficacy of a biologic agent in the treatment of axial manifestations in PsA.

General Rheumatology

JAK Inhibitor and Type I Interferon Possible Treatments for COVID-19

Estie Mermelstein, MSN, FNP-BC

March 2, 2021

Study authors conducted a systematic review and meta-analysis to assess the efficacy of Janus kinase-inhibitors and Type I interferons as potential antiviral candidates for the treatment of COVID-19.

General Rheumatology

Blood Types O and Rh-Negative Protective Against COVID-19

Estie Mermelstein, MSN, FNP-BC

February 16, 2021

Investigators determined whether ABO and Rh blood groups were associated with risk for SARS-CoV-2 infection and severe COVID-19 illness.

Pediatric Rheumatology

Evaluating Mucocutaneous Symptoms of Multisystem Inflammatory Syndrome in Pediatric Patients

Estie Mermelstein, MSN, FNP-BC

February 3, 2021

The mucocutaneous features seen in hospitalized children with MIS-C and how these findings are associated with the onset of systemic symptoms are characterized.

Next post in Pediatric Rheumatology